<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xie R</submitter><funding>NCI NIH HHS</funding><pagination>1601-1610</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6548004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(7)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> One of our previous studies have demonstrated that the cancer suppressor miR-150 regulated the progression of colorectal cancer (CRC) by down-regulating v-myb avian myeloblastosis viral oncogene homolog (c-Myb). The purpose of present study was to evaluate the prognostic value of the expression of c-Myb and its effector, prostaglandin-endoperoxide synthase 2 (COX-2) in patients with CRC. &lt;b>Methods:&lt;/b> We used tissue microarrays (containing 202 CRC tissues and matched adjacent normal tissues) and conducted immunohistochemical analysis and western blotting analysis (containing 3 CRC tissues and matched adjacent normal tissues) to detect the expression of c-Myb and COX-2. &lt;b>Results:&lt;/b> Compared with the adjacent nontumorous tissues, both the expression levels of c-Myb a</pubmed_abstract><journal>Journal of Cancer</journal><pubmed_title>c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer.</pubmed_title><pmcid>PMC6548004</pmcid><funding_grant_id>R01 CA202797</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Goel A</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Wei Q</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Qin H</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Xie R</pubmed_authors></additional><is_claimable>false</is_claimable><name>c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer.</name><description>&lt;b>Background:&lt;/b> One of our previous studies have demonstrated that the cancer suppressor miR-150 regulated the progression of colorectal cancer (CRC) by down-regulating v-myb avian myeloblastosis viral oncogene homolog (c-Myb). The purpose of present study was to evaluate the prognostic value of the expression of c-Myb and its effector, prostaglandin-endoperoxide synthase 2 (COX-2) in patients with CRC. &lt;b>Methods:&lt;/b> We used tissue microarrays (containing 202 CRC tissues and matched adjacent normal tissues) and conducted immunohistochemical analysis and western blotting analysis (containing 3 CRC tissues and matched adjacent normal tissues) to detect the expression of c-Myb and COX-2. &lt;b>Results:&lt;/b> Compared with the adjacent nontumorous tissues, both the expression levels of c-Myb a</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-06-03T16:43:11.179Z</modification><creation>2019-07-24T07:09:32Z</creation></dates><accession>S-EPMC6548004</accession><cross_references><pubmed>31205515</pubmed><doi>10.7150/jca.27261</doi></cross_references></HashMap>